IPO

Reliance Jio Q1 FY25 reports positive signs for its future prospects, Reliance Jio IPO awaited!

by
Reliance Jio Q1 FY25 reports Reliance Jio IPO awaited!

Reliance Jio, the telecom arm of Reliance Industries Limited (RIL), reported a strong performance in Q1 FY25, with a 12% year-on-year increase in net profit to ₹5,445 crore. This growth was driven by a 10.33% rise in operating revenue to ₹26,478 crore, primarily due to an increase in subscribers and data consumption. Reliance Jio Q1 Read more: Reliance Jio Q1 FY25 reports positive signs for its future prospects, Reliance Jio IPO awaited!..

US IPO market reaches two-year high in Q2 as activity surges

by
US IPO market reaches two-year high in Q2 as activity surges

The US IPO market reach a two-year high in the second quarter of 2024, with 35 IPOs launched. However, the market is still recovering and not yet back to pre-pandemic levels. The second quarter of 2024 saw a surge in IPOs, the highest number since the first quarter of 2022. Despite the increase in activity, Read more: US IPO market reaches two-year high in Q2 as activity surges..

Emcure Pharma IPO Details – Namita Thapar may gain Rs.127 crore

by
Emcure Pharma IPO Details - Namita Thapar

The Emcure Pharma IPO to open for subscription tomorrow, July 3, 2024, and will close on July 5, 2024. Namita Thapar, a Shark Tank India investor and member of the Emcure Pharmaceuticals promoter group, is expected to sell part of her holdings in the IPO, estimated to be worth ₹127 crore. Here’s a summary of Read more: Emcure Pharma IPO Details – Namita Thapar may gain Rs.127 crore..